Download the case study "Helping a top-10 pharma develop an organoid-based predictive toxicology model"

Complete the form to learn how a top-10 pharma company’s toxicology group leveraged extensive, authoritative data to develop a predictive toxicology model.

Cover banner for predictive toxicology case study

As this group looked to shift away from animal testing to more reliable and ethical alternatives, Elsevier combined its data, tools, and expertise to provide a machine-readable custom dataset to inform an organoid-based predictive toxicology model. The dataset consisted of a ranked list of drugs with corresponding information on the reported incidence and severity of the adverse event in question, as well as other details essential to establishing an evidence-based calibration curve for more accurate predictions.

Get access to the full story and let us know if you would like to hear more about Elsevier’s data solutions.